CRISPR-Cas-Based Engineering of Probiotics

被引:16
|
作者
Liu, Ling [1 ,2 ]
Helal, Shimaa Elsayed [1 ]
Peng, Nan [1 ]
机构
[1] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Hubei Hongshan Lab, Wuhan 430070, Hubei, Peoples R China
[2] CABIO Biotech Wuhan Co Ltd, Wuhan, Peoples R China
来源
BIODESIGN RESEARCH | 2023年 / 5卷
基金
中国国家自然科学基金;
关键词
RNA; DNA; SYSTEMS; TOOL; ENDONUCLEASE; IMPROVEMENT; MECHANISMS; STRAINS;
D O I
10.34133/bdr.0017
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Probiotics are the treasure of the microbiology fields. They have been widely used in the food industry, clinical treatment, and other fields. The equivocal health-promoting effects and the unknown action mechanism were the largest obstacles for further probiotic's developed applications. In recent years, various genome editing techniques have been developed and applied to explore the mechanisms and functional modifications of probiotics. As important genome editing tools, CRISPR-Cas systems that have opened new improvements in genome editing dedicated to probiotics. The high efficiency, flexibility, and specificity are the advantages of using CRISPR-Cas systems. Here, we summarize the classification and distribution of CRISPR-Cas systems in probiotics, as well as the editing tools developed on the basis of them. Then, we discuss the genome editing of probiotics based on CRISPR-Cas systems and the applications of the engineered probiotics through CRISPR-Cas systems. Finally, we proposed a design route for CRISPR systems that related to the genetically engineered probiotics.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] CRISPR-Cas-based plant genome engineering goes viral
    Daros, Jose-Antonio
    Pasin, Fabio
    Merwaiss, Fernando
    MOLECULAR PLANT, 2023, 16 (04) : 660 - 661
  • [2] Emergent CRISPR-Cas-based technologies for engineering non-model bacteria
    Volke, Daniel C.
    Orsi, Enrico
    Nikel, Pablo I.
    CURRENT OPINION IN MICROBIOLOGY, 2023, 75
  • [3] CRISPR-Cas-based biosensors for the detection of cancer biomarkers
    Feng, Yuxin
    Yang, Jinmeng
    He, Ziping
    Liu, Xinfa
    Ma, Changbei
    ANALYTICAL METHODS, 2024, 16 (39) : 6634 - 6653
  • [4] The use of CRISPR-Cas-based systems in bacterial cell factories
    Kolasinliler, Gulsen
    Aagre, Mehdi Movahed
    Akkale, Cengiz
    Kaya, Hilal Betul
    BIOCHEMICAL ENGINEERING JOURNAL, 2023, 194
  • [5] CRISPR-Cas-based colorimetric strategies for nucleic acids detection
    Yang, Yujin
    Li, Xingyu
    Wang, Xiaobo
    Wang, Zongji
    Gong, Shaohua
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2025, 182
  • [6] Development of CRISPR-Cas-based strategies for spinocerebellar ataxia type 2
    Koppenol, R.
    Matos, C. A.
    Afonso-Reis, R.
    Almeida, L. P.
    Nobrega, C.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A152 - A153
  • [7] Photoswitchable gRNAs for Spatiotemporally Controlled CRISPR-Cas-Based Genomic Regulation
    Moroz-Omori, Elena, V
    Satyapertiwi, Dwiantari
    Ramel, Marie-Christine
    Hogset, Hakon
    Sunyovszki, Ilona K.
    Liu, Ziqian
    Wojciechowski, Jonathan P.
    Zhang, Yueyun
    Grigsby, Christopher L.
    Brito, Liliana
    Bugeon, Laurence
    Dallman, Margaret J.
    Stevens, Molly M.
    ACS CENTRAL SCIENCE, 2020, 6 (05) : 695 - 703
  • [8] CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
    Mayorga-Ramos, Arianna
    Zuniga-Miranda, Johana
    Carrera-Pacheco, Saskya E.
    Barba-Ostria, Carlos
    Guaman, Linda P.
    ACS INFECTIOUS DISEASES, 2023, 9 (07): : 1283 - 1302
  • [9] CRISPR-Cas-based assays for the detection of SARS-CoV-2 RNA
    Ito, T.
    Bandaru, S.
    Lee, S.
    Kumagai-Takei, N.
    Yoshitome, K.
    Shimizu, Y.
    Sada, N.
    Nishimura, Y.
    Otsuki, T.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (03): : 39 - 44
  • [10] Native CRISPR-Cas-based programmable multiplex gene repression in Klebsiella variicola
    Mo, Zhifeng
    Lin, Siying
    Li, Ting
    Yu, Guohui
    Sun, Yunhao
    Zhou, Jianuan
    Xu, Zeling
    BIOTECHNOLOGY LETTERS, 2024, 46 (06) : 973 - 982